A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

被引:0
作者
Jan S. A. G. Schouten
Ellen C. La Heij
Carroll A. B. Webers
Igor J. Lundqvist
Fred Hendrikse
机构
[1] Maastricht University Hospital,Department of Ophthalmology
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2009年 / 247卷
关键词
Systematic review; Bevacizumab; Exudative macular degeneration; Visual acuity; Retinal thickness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration
    Lee, In Ho
    Lee, Jae Jung
    Kwon, Han Jo
    Park, Sung Who
    Lee, Ji Eun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (01): : 40 - 46
  • [32] A Systematic Review on Zinc for the Prevention and Treatment of Age-Related Macular Degeneration
    Vishwanathan, Rohini
    Chung, Mei
    Johnson, Elizabeth J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (06) : 3985 - 3998
  • [33] Radiotherapy of exudative age-related macular degeneration; a clinical and pathologic study
    Antoinette C. Lambooij
    Robert W. Kuijpers
    Cornelia M. Mooy
    Mike Kliffen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2001, 239 : 539 - 543
  • [34] INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Hautamaki, Asta
    Kivioja, Jarno
    Vavuli, Satu
    Kakko, Sakari
    Savolainen, Eeva-Riitta
    Savolainen, Markku J.
    Liinamaa, M. Johanna
    Seitsonen, Sanna
    Onkamo, Paivi
    Jarvela, Irma
    Immonen, Ilkka
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (09): : 1815 - 1827
  • [35] Accessibility as a conditioning factor in treatment for exudative age-related macular degeneration
    Real, Juan P.
    Luna, Jose D.
    Urrets-Zavalia, Julio A.
    De Santis, Mariana O.
    Palma, Santiago D.
    Granero, Gladys E.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (06) : 857 - 864
  • [36] Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
    Hara, Chikako
    Wakabayashi, Taku
    Fukushima, Yoko
    Sayanagi, Kaori
    Kawasaki, Ryo
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (11) : 2559 - 2569
  • [37] A Systematic Review of Clinical Practice Guidelines for Age-related Macular Degeneration
    Han, Xiaotong
    Chen, Yanxian
    Gordon, Iris
    Safi, Sare
    Lingham, Gareth
    Evans, Jennifer
    Keel, Stuart
    He, Mingguang
    OPHTHALMIC EPIDEMIOLOGY, 2023, 30 (03) : 213 - 220
  • [38] Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
    Doguizi, Sibel
    Ozdek, Sengul
    Yuksel, Selcen
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 846 - 848
  • [39] Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration
    Ueda-Arakawa, Naoko
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Ooto, Sotaro
    Tamura, Hiroshi
    Yoshimura, Nagahisa
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2012, 56 (06) : 589 - 598
  • [40] Comparative Review of Ranibizumab versus Bevacizumab in the Treatment of Neovascular Age-related Macular Degeneration
    Heroman, J. Wesley
    Kaplan, Henry J.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 491 - 497